NCPA Addresses "Lock-In" Pharmacy Legislation


The National Community Pharmacists Association has written lawmakers to provide pharmacists' feedback and recommendations to improve so-called "lock-in pharmacy" provisions within H.R. 1021.


ALEXANDRIA, Va. (Feb. 26, 2015) — In advance of a committee vote regarding Medicare legislation, the National Community Pharmacists Association (NCPA) has written lawmakers to provide pharmacists’ feedback and recommendations to improve the measure. (To download the letter, click here.)

The House Ways & Means Committee has scheduled a vote today on H.R. 1021. NCPA’s comments focused on so-called “lock-in pharmacy” provisions within H.R. 1021 that would restrict the ability of Medicare beneficiaries to obtain prescribed narcotic painkillers if the patients are deemed to be at “high risk” of prescription drug abuse.

“Lock-in pharmacy initiatives in state Medicaid programs virtually always include the ‘lock-in’ of both prescriber and pharmacy because a coordinated approach to patient care is essential to the success of any such program,” said NCPA CEO B. Douglas Hoey, RPh, MBA. “The committee’s proposal to require the ‘lock-in’ of both a prescriber and a pharmacy is an improvement compared to proposals that overlook prescribing. The prescription drug abuse epidemic is complex and wide-ranging in nature and at the forefront of prevention efforts must be a focus on reducing the inappropriate prescribing.”

NCPA has serious concerns about granting plan sponsors unilateral authority to require certain Medicare beneficiaries to use a particular pharmacy for their prescribed controlled substances, because drug plan sponsors may simply assign beneficiaries to pharmacies that the sponsor owns or in which it has a financial interest. Already Part D plans exclude independent community pharmacies from many “preferred” pharmacy networks.

NCPA’s letter offered lawmakers specific proposals, including the following, to further safeguard timely access to controlled substances for patients with legitimate medical needs.

  • Strengthen beneficiary protections to help prevent the mandated use of pharmacies owned by or affiliated with the drug plan sponsor.
  • Clarify exempted individuals to include patients in long-term care settings and those suffering intractable pain, such as due to an advanced cancer diagnosis.
  • Greater use of existing authorities already available to combat prescription drug abuse.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U -
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii |
Pharmacy Interior | Image Credit: Tyler Olson -
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi -
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen |
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/ |
Image credit: fidaolga -
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund |
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi -
© 2023 MJH Life Sciences

All rights reserved.